← 產業報告目錄
Bioresorbable Vascular Scaffold Market Size, Share & Trends Analysis Report By Product Type (Enviroximes-eluting Device, Novalis’s-eluting Device, Sirolimus-eluting Device. Others), By Disease Type, By Material Type, By End-user, By Region, And by Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-19頁數 180報告編號 INSIGHTACE-c64570b677
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
In 2024, the Bioresorbable Vascular Scaffold Market worldwide was assessed at USD 179.7 Mn. Analysts project it will accelerate to USD 375.6 Mn by 2034, at a CAGR of 7.8% spanning 2025 to 2034.
At its core, Bioresorbable Vascular Scaffold pertains to The market for bioresorbable scaffolds is growing due to an increase in acceptance of cardiovascular procedures due to the advantages provided, including full body absorption and an increase in lifest. Stakeholders across the healthcare landscape are risingly turning to these solutions to meet contemporary demands.
Market momentum is fueled by rising appetite for advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, fueled by rapid industrialization and expanding end-user bases.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Bioresorbable Vascular Scaffold Market Snapshot
Chapter 4. Global Bioresorbable Vascular Scaffold Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends Investment and Funding Analysis of Metaverse Industry
4.5. Industry Analysis – Porter's Five Forces Analysis
4.6. COVID-19 Impact on Industry
Chapter 5. Market Segmentation 1: By Product Type Estimates & Trend Analysis
5.1. By Product Type & Market Share, 2024-2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Product Type:
5.2.1. Everolimus-eluting Device
5.2.2. Novolimus-eluting Device
5.2.3. Sirolimus-eluting Device
5.2.4. Others (Rapamycin, etc.)
Chapter 6. Market Segmentation 2: By Disease Type Estimates & Trend Analysis
6.1. By Product Type & Market Share, 2024-2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Disease Type:
6.2.1. Coronary Artery Disease
6.2.2. Peripheral Artery Disease
Chapter 7. Market Segmentation 3: By Material Type Estimates & Trend Analysis
7.1. By Product Type & Market Share, 2024-2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Material Type:
7.2.1. Poly-L-Lactic Acid (PLLA)
7.2.2. Tyrosine-derived Polycarbonate
7.2.3. Others (Polydioxanone, etc.)
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. By Product Type & Market Share, 2024-2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End User:
8.2.1.1. Hospital
8.2.1.2. Ambulatory Surgical Center
8.2.1.3. Cardiac Catheterization Lab
8.2.1.4. Others (research institutes, etc.)
Chapter 9. Bioresorbable Vascular Scaffold Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Bioresorbable Vascular Scaffold Market revenue (US$ Million) estimates and forecasts By Product Type, 2021-2034
9.1.2. North America Bioresorbable Vascular Scaffold Market revenue (US$ Million) estimates and forecasts By Disease Type, 2021-2034
9.1.3. North America Bioresorbable Vascular Scaffold Market revenue (US$ Million) estimates and forecasts By Material Type, 2021-2034
9.1.4. North America Bioresorbable Vascular Scaffold Market revenue (US$ Million) estimates and forecasts By, End User 2021-2034
9.1.5. North America Bioresorbable Vascular Scaffold Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
9.1.5.1. U.S.
9.1.5.2. Canada
9.2. Europe
9.2.1. Europe Bioresorbable Vascular Scaffold Market revenue (US$ Million) by By Product Type, 2021-2034
9.2.2. Europe Bioresorbable Vascular Scaffold Market revenue (US$ Million) estimates and forecasts By Disease Type, 2021-2034
9.2.3. Europe Bioresorbable Vascular Scaffold Market revenue (US$ Million) estimates and forecasts By Material Type 2021-2034
9.2.4. Europe Bioresorbable Vascular Scaffold Market revenue (US$ Million) estimates and forecasts By End User,2021-2034
9.2.5. Europe Bioresorbable Vascular Scaffold Market revenue (US$ Million) by country, 2021-2034
9.2.5.1. Germany
9.2.5.2. Poland
9.2.5.3. France
9.2.5.4. Italy
9.2.5.5. Spain
9.2.5.6. UK
9.2.5.7. Rest of Europe
9.3. Asia Pacific
9.3.1. Asia Pacific Bioresorbable Vascular Scaffold Market revenue (US$ Million) by By Product Type, 2021-2034
9.3.2. Asia Pacific Bioresorbable Vascular Scaffold Market revenue (US$ Million) estimates and forecasts By Disease Type, 2021-2034
9.3.3. Asia Pacific Bioresorbable Vascular Scaffold Market revenue (US$ Million) estimates and forecasts By Material Type, 2021-2034
9.3.4. Asia Pacific Bioresorbable Vascular Scaffold Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
9.3.5. Asia Pacific Bioresorbable Vascular Scaffold Market revenue (US$ Million) by country, 2021-2034
9.3.5.1. China
9.3.5.2. India
9.3.5.3. Japan
9.3.5.4. Australia
9.3.5.5. Rest of Asia Pacific
9.4. Latin America
9.4.1. Latin America Bioresorbable Vascular Scaffold Market revenue (US$ Million) by By Product Type, 2021-2034
9.4.2. Latin America Bioresorbable Vascular Scaffold Market revenue (US$ Million) estimates and forecasts By Disease Type, 2021-2034
9.4.3. Latin America Bioresorbable Vascular Scaffold Market revenue (US$ Million) estimates and forecasts By Material Type, 2021-2034
9.4.4. Latin America Bioresorbable Vascular Scaffold Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
9.4.5. Latin America Bioresorbable Vascular Scaffold Market revenue (US$ Million) by country, (US$ Million) 2021-2034
9.4.5.1. Brazil
9.4.5.2. Rest of Latin America
9.5. Middle East & Africa
9.5.1. Middle East & Africa Bioresorbable Vascular Scaffold Market revenue (US$ Million) by By Product Type, (US$ Million)
9.5.2. Middle East & Africa Bioresorbable Vascular Scaffold Market revenue (US$ Million) estimates and forecasts By Disease Type, 2021-2034
9.5.3. Middle East & Africa Bioresorbable Vascular Scaffold Market revenue (US$ Million) estimates and forecasts By Material Type, 2021-2034
9.5.4. Middle East & Africa Bioresorbable Vascular Scaffold Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
9.5.5. Middle East & Africa Bioresorbable Vascular Scaffold Market revenue (US$ Million) by country, (US$ Million) 2021-2034
9.5.5.1. South Africa
9.5.5.2. GCC Countries
9.5.5.3. Rest of MEA
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Kyoto Medical Planning Co., Ltd.
10.2.2. BIOTRONIK Group of Companies.
10.2.3. REVA Medical
10.2.4. Elixir Medical
10.2.5. Arterius
10.2.6. Meril Life Sciences Pvt. Ltd.
10.2.7. S3V Vascular Technologies
10.2.8. Zorion Medical
10.2.9. Medtronic (development phase)
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們